SurgoCap Partners’s Core & Main CNM Stock Holding History

SurgoCap Partners’s Portfolio CNM Stock Details CNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,075,233	Closed	-$102M	–	13
2024 Q2	$102M	Buy	+2,075,233	New	+$115M	5.94%	9

Other funds holding CNM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ACM

Anomaly Capital Management New York $2.62B AUM 23.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return

SurgoCap Partners's CNM Position: Q3 2024 in Review

SurgoCap Partners sold out of Core & Main (CNM) in Q3 2024, closing a stake of 2,075,233 shares — an estimated $102M sold.

SurgoCap Partners first reported a position in CNM in Q2 2024 and held it in 1 quarter. The position peaked at $102M in Q2 2024. 389 funds tracked by Wall St. Rank hold CNM as of Q3 2024.

SurgoCap Partners reported no remaining Core & Main position as of Q3 2024 after selling out during the quarter.
SurgoCap Partners sold 2,075,233 Core & Main shares in Q3 2024, an estimated $102M.
SurgoCap Partners first reported a position in Core & Main in Q2 2024 and held it in 1 quarter.
SurgoCap Partners's Core & Main position peaked at $102M in Q2 2024.
389 funds tracked by Wall St. Rank held Core & Main as of Q3 2024.

Based on SurgoCap Partners's 13F filing for Q3 2024, filed 14 Nov 2024.